Erratum: Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))

H. M. Kantarjian, J. E. Cortes, D. W. Kim

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume124
Issue number6
StatePublished - Aug 7 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this